Page 4,924«..1020..4,9234,9244,9254,926..4,9304,940..»

Clinical trial into MS 'liberation treatment' cancelled due to lack of participants

Posted: Published on September 10th, 2013

CTVNews.ca Staff Published Monday, September 9, 2013 3:41PM EDT Last Updated Monday, September 9, 2013 8:11PM EDT Canadians who were among multiple sclerosis sufferers waiting to take part in a clinical trial into the so-called liberation treatment were disappointed on Monday by news that the trial was cancelled. The Saskatchewan government was told that the Albany Medical Centre in New York has stopped its trial into the effectiveness of angioplasty in treating CCSVI (chronic cerebro-spinal venous insufficiency) and relieving symptoms of multiple sclerosis. The treatment involves opening blocked neck veins. There were 86 planned participants from Saskatchewan -- a province home to one of the highest rates of M.S. sufferers compared to the rest of Canada. The province had committed up to $2.2 million to have its patients participate in the Albany study. Clinical trial lead Dr. Gary Siskin told Saskatchewans Ministry of Health that he wasnt able to meet the overall target enrolment needed for the study to meet U.S. government requirements for a clinical trial. Siskin told CTV News that hes very disappointed the trial had to be cancelled. He spoke about the difficulty in getting people to enrol in the study, as participants seemed reluctant because of … Continue reading →

Posted in MS Treatment | Comments Off on Clinical trial into MS 'liberation treatment' cancelled due to lack of participants

Clinical trial into MS 'liberation treatment' cancelled

Posted: Published on September 10th, 2013

CTVNews.ca Staff Published Monday, September 9, 2013 3:41PM EDT Last Updated Monday, September 9, 2013 8:11PM EDT Canadians who were among multiple sclerosis sufferers waiting to take part in a clinical trial into the so-called liberation treatment were disappointed on Monday by news that the trial was cancelled. The Saskatchewan government was told that the Albany Medical Centre in New York has stopped its trial into the effectiveness of angioplasty in treating CCSVI (chronic cerebro-spinal venous insufficiency) and relieving symptoms of multiple sclerosis. The treatment involves opening blocked neck veins. There were 86 planned participants from Saskatchewan -- a province home to one of the highest rates of M.S. sufferers compared to the rest of Canada. The province had committed up to $2.2 million to have its patients participate in the Albany study. Clinical trial lead Dr. Gary Siskin told Saskatchewans Ministry of Health that he wasnt able to meet the overall target enrolment needed for the study to meet U.S. government requirements for a clinical trial. Siskin told CTV News that hes very disappointed the trial had to be cancelled. He spoke about the difficulty in getting people to enrol in the study, as participants seemed reluctant because of … Continue reading →

Posted in MS Treatment | Comments Off on Clinical trial into MS 'liberation treatment' cancelled

Huda Y. Zoghbi, M.D. to Receive the 2013 Pearl Meister Greengard Prize

Posted: Published on September 10th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? Nightline Fix … Continue reading →

Comments Off on Huda Y. Zoghbi, M.D. to Receive the 2013 Pearl Meister Greengard Prize

The New Protocols and Standards of One of Florida's Leading Testosterone Therapy Programs — Testosterone149

Posted: Published on September 10th, 2013

Palm Beach, Florida (PRWEB) September 09, 2013 Clinics have been popping up everywhere and private-physician practices suddenly take pride in their hormone-therapy expertise. Be smarter and get the right information! Dr. Berman a leading physician and founder of the Testosterone149 Program has been practicing Hormone Replacement Therapy for over 15 years. Originally trained in urology and surgery, Dr. Berman is a true expert when it comes to Hormone Replacement Therapy. His thorough knowledge in this specialty stems from extensive research and fellowship programs, as well as from years of specializing in Hormone Correction. The Testosterone149 Program was designed for the 'Aging Male,' a term that encompasses men over the age of 40 who experience symptoms of Erectile Dysfunction, Depression, Irritability, Excessive Weight Gain and Sleepless Nights. These are our patients and are the ideal candidates for our program," explains Dr. Berman. "Not the 32-year-old calling our offices claiming they would like to work out harder and look better at the gym." Essentially, the younger the man, the more scrutinizing the lab profile workup should be, says Dr. Berman, claiming that a healthy 40-year-old should not suffer from low Testosterone. But if that is the case, it may be due to … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on The New Protocols and Standards of One of Florida's Leading Testosterone Therapy Programs — Testosterone149

Research and Markets: Cancer Stem Cells Drug Pipeline Update 2013

Posted: Published on September 10th, 2013

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/82v6t2/cancer_stem_cells) has announced the addition of the "Cancer Stem Cells Drug Pipeline Update 2013" report to their offering. Treatments designed to target and destroy cancer stem cells may come to revolutionize how we treat cancer. This unique product covers both explicit cancer stem cell drug development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today 308 companies plus partners developing 478 cancer stem cells and developmental pathways drugs in 1568 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 232 drugs. Cancer Stem Cells Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 257 different targets. All included targets have been cross-referenced for the presence of mutations associated with human cancer. To date 250 out of the 253 studied drug targets so far have been recorded with somatic mutations. All drugs targets are further categorized on in the software application by … Continue reading →

Posted in Stem Cell Research | Comments Off on Research and Markets: Cancer Stem Cells Drug Pipeline Update 2013

Early-onset Parkinson's disease linked to genetic deletion

Posted: Published on September 10th, 2013

TORONTO, Sept. 9, 2013 /CNW/ - Scientists at the Centre for Addiction and Mental Health (CAMH) and University Health Network (UHN) have found a new link between early-onset Parkinson's disease and a piece of DNA missing from chromosome 22. The findings help shed new light on the molecular changes that lead to Parkinson's disease. The study appears online today in JAMA Neurology. Among people aged 35 to 64 who were missing DNA from a specific part of chromosome 22, the research team found a marked increase in the number of cases of Parkinson's disease, compared to expected rates of Parkinson's disease in the general population from the same age group. The deletion, which occurs when a person is born with about 50 genes missing on one chromosome 22, is associated with 22q11.2 deletion syndrome. People with this condition may have heart or other birth defects, learning or speech difficulties, and some develop schizophrenia. It occurs in an estimated 1 in 2,000 to 4,000 births, but is believed to be under-diagnosed. "22q11.2 deletion syndrome has been fairly well studied in childhood and adolescence, but less is known about its effects as people age," said Dr. Anne Bassett, Director of CAMH's Clinical … Continue reading →

Comments Off on Early-onset Parkinson's disease linked to genetic deletion

The endless debate over genetic engineering

Posted: Published on September 10th, 2013

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Mobile Yahoo! News Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Sideshow Katie's Take Power Players This Could Be Big Newsmakers Trending Now The Upbeat Who Knew? Nightline Fix … Continue reading →

Comments Off on The endless debate over genetic engineering

Stem Cell Therapy For Pets – Video

Posted: Published on September 10th, 2013

Stem Cell Therapy For Pets Stemcellvet.co.uk offer adipose derived Stem Cell Therapy for pets in the UK. We treat cats and dogs predominantly for arthritis but there is also the potent... By: stemcellvet.co.uk … Continue reading →

Comments Off on Stem Cell Therapy For Pets – Video

Orange County Stem Cell Clinic, TeleHealth, Now Offering Insurance-Covered Regenerative Medicine Treatments

Posted: Published on September 10th, 2013

Orange County, CA (PRWEB) September 09, 2013 The leading regenerative medicine clinic on the West Coast, TeleHealth, is now offering multiple stem cell therapy treatments for arthritis and soft tissue injury such as tendonitis of the shoulder. The injection treatments are covered by insurance, and are offered with Board Certified doctors. For more information and scheduling, call (888) 828-4575. Regenerative medicine with stem cell therapy represents the latest, cutting edge technology for healing degenerative conditions. The stem cell injection treatments possess the potential for actually repairing the cartilage damage in arthritic joints or tendon damage in an injured shoulder. For an individual attempting to avoid surgery such as a joint replacement or a shoulder arthroscopy, stem cell therapy at TeleHealth may be just the option to allow that. There are multiple regenerative medicine options provided at the TeleHealth clinic including platelet rich plasma therapy (PRP), bone marrow-derived stem cell injections as well as those derived from fat. The injections are all done as an outpatient and since the stem cells are harvested from the patient, the risks are extremely low. Stem cells are crucial for rebuilding damaged tissue as they differentiate into the necessary cells such as cartilage or tendon … Continue reading →

Comments Off on Orange County Stem Cell Clinic, TeleHealth, Now Offering Insurance-Covered Regenerative Medicine Treatments

International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage

Posted: Published on September 10th, 2013

CARLSBAD, CA--(Marketwired - Sep 9, 2013) - International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies, announced today further progress in its Parkinson's disease program with a recently held key opinion leader meeting facilitated by the study's principal investigator, Dr. Mark Stacy of Duke Medicine. The meeting was a significant step towards clinical studies to evaluate the use of stem cell-derived neuronal cells to treat Parkinson's disease (PD). By bringing together leading experts from throughout North America in the field of cell therapy and movement disorders, ISCO gains critical feedback and guidance that can be included in the final pre-clinical primate studies and the design of the first-in-man study, which is expected to begin in 2014. "This is an interesting new approach for the treatment of PD," said Stacy, Vice Dean for Clinical Research, Neurology at Duke University School of Medicine. "This meeting increases the chances of a successful clinical outcome by allowing us to not only build on previous studies, but also gain in-depth insight from some of the principal clinicians and neurosurgeons working in this field." The participants, consisting of a number of pre-eminent clinicians, some of whom have conducted cell … Continue reading →

Comments Off on International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage

Page 4,924«..1020..4,9234,9244,9254,926..4,9304,940..»